文献速递真菌感染

既往健康隐球菌脑膜脑炎患者脉冲减量糖皮质激素治疗感染后炎症综合征的结局

Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients Treated With Pulse Taper Corticosteroids for Post-infectious Inflammatory Syndrome.
PubMed 文献 · Clin Infect Dis · 2021-01-01

这项研究纳入15例既往健康且合并感染后炎症反应综合征(PIIRS)的隐球菌脑膜脑炎患者,在抗真菌治疗基础上给予脉冲糖皮质激素减量治疗(PCT)。结果显示治疗后1个月认知与功能评分显著改善,脑脊液炎症指标及影像学、视听觉并发症亦好转,且急性期毒性轻微。

要点

  • 既往健康隐球菌脑膜脑炎合并PIIRS者,在抗真菌治疗基础上可考虑脉冲糖皮质激素减量治疗。
  • 该治疗与认知功能、脑脊液炎症指标及影像学改善相关,视乳头水肿和视野缺损亦好转。
  • 小样本研究提示急性期毒性轻微,但需警惕激素相关风险并个体化评估。

核心结论

  • 在这小样本PIIRS队列中,脉冲糖皮质激素减量治疗与隐球菌脑膜脑炎相关并发症改善相关,急性期毒性轻微。

研究设计与样本

  • 2015年3月至2020年3月连续纳入15例既往健康且合并PIIRS的隐球菌脑膜脑炎患者,给予辅助脉冲糖皮质激素减量治疗(静脉甲泼尼龙1 gm/日×1周,继以口服泼尼松1 mg/kg/日按临床和影像学反应减量)联合口服氟康唑。

主要发现

  • 从抗真菌治疗到启动激素的中位时间为6周。
  • PIIRS诊断时最常见症状为精神状态改变和视力变化。
  • 所有患者1个月时MOCA和Karnofsky评分显著改善(P < .0003)。
  • 接受激素1周后脑脊液葡萄糖、白细胞计数、蛋白及细胞和可溶性炎症标志物改善(P < .003)。
  • 所有视乳头水肿和视野缺损患者均改善(P < .0005);7例接受听力测试者中5例听力改善;脑MRI放射学表现显著改善(P = .001);脑脊液培养持续阴性。

关键数值与推荐

  • 辅助脉冲激素方案:静脉甲泼尼龙1 gm/日×1周,继以口服泼尼松1 mg/kg/日,根据临床和影像学反应减量,联合口服氟康唑。
  • 从抗真菌治疗到激素启动的中位时间为6周。
  • 1个月时MOCA和Karnofsky评分改善P < .0003;激素1周后脑脊液炎症指标改善P < .003;视乳头水肿和视野缺损改善P < .0005;脑MRI改善P = .001。

临床怎么用

  • 对既往健康隐球菌脑膜脑炎合并PIIRS且脑脊液培养阴性者,在抗真菌治疗基础上可考虑辅助脉冲糖皮质激素减量治疗。
  • 治疗期间应监测认知功能、脑脊液炎症指标、影像学及视听觉并发症变化。
  • 该方案急性期毒性轻微,但仍需个体化评估激素风险与获益。

局限性

  • 样本量小(15例),为单中心连续病例,缺乏对照。
  • 部分结局(如听力)仅7例接受测试,数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cryptococcal meningoencephalitis (CM) is a major cause of mortality in immunosuppressed patients and previously healthy individuals. In the latter, a post-infectious inflammatory response syndrome (PIIRS) is associated with poor clinical response despite antifungal therapy and negative cerebrospinal fluid (CSF) cultures. Data on effective treatment are limited. METHODS: Between March 2015 and March 2020, 15 consecutive previously healthy patients with CM and PIIRS were treated with adjunctive pulse corticosteroid taper therapy (PCT) consisting of intravenous methylprednisolone 1 gm daily for 1 week followed by oral prednisone 1 mg/kg/day, tapered based on clinical and radiological response plus oral fluconazole. Montreal cognitive assessments (MOCA), Karnofsky performance scores, magnetic resonance imaging (MRI) brain scanning, ophthalmic and audiologic exams, and CSF parameters including cellular and soluble immune responses were compared at PIIRS diagnosis and after methylprednisolone completion. RESULTS: The median time from antifungal treatment to steroid initiation was 6 weeks. The most common symptoms at PIIRS diagnosis were altered mental status and vision changes. All patients demonstrated significant improvements in MOCA and Karnofsky scores at 1 month (P < .0003), which was accompanied by improvements in CSF glucose, white blood cell (WBC) count, protein, cellular and soluble inflammatory markers 1 week after receiving corticosteroids (CS) (P < .003). All patients with papilledema and visual field deficits also exhibited improvement (P < .0005). Five out of 7 patients who underwent audiological testing demonstrated hearing improvement. Brain MRI showed significant improvement of radiological findings (P = .001). CSF cultures remained negative. CONCLUSIONS: PCT in this small cohort of PIIRS was associated with improvements in CM-related complications with minimal toxicity in the acute setting.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Anjum S, Dean O, Kosa P, et al. Outcomes in Previously Healthy Cryptococcal Meningoencephalitis Patients Treated With Pulse Taper Corticosteroids for Post-infectious Inflammatory Syndrome. Clin Infect Dis. 2021. PMID: 33383587. doi:10.1093/cid/ciaa1901

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。